Literature DB >> 27558986

Tofacitinib for polyarteritis nodosa: a tailored therapy.

Doron Rimar1, Ayelet Alpert2, Elina Starosvetsky2, Itzhak Rosner1, Gleb Slobodin1, Michael Rozenbaum1, Lisa Kaly1, Nina Boulman1, Abid Awisat1, Shira Ginsberg1, Karina Zilber1, Shai S Shen-Orr2,3.   

Abstract

Entities:  

Keywords:  Cytokines; Systemic vasculitis; Treatment

Mesh：

Substances：

Year:  2016        PMID： 27558986     DOI： 10.1136/annrheumdis-2016-209330

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  15 in total

1.  JAK-inhibition as a therapeutic strategy for refractory primary systemic vasculitides.

Authors:  Sujoy Khan
Journal:  Clin Med (Lond)       Date:  2021-03       Impact factor: 2.659

Review 2.  Clinical Approach to Diagnosis and Therapy of Polyarteritis Nodosa.

Authors:  Alojzija Hočevar; Matija Tomšič; Katja Perdan Pirkmajer
Journal:  Curr Rheumatol Rep       Date:  2021-02-10       Impact factor: 4.592

Review 3.  Infliximab for the treatment of refractory polyarteritis nodosa.

Authors:  Shira Ginsberg; Itzhak Rosner; Gleb Slobodin; Michael Rozenbaum; Lisa Kaly; Nizar Jiries; Nina Boulman; Abid Awisat; Haya Hussein; Irina Novofastovski; Amal Silawy; Doron Rimar
Journal:  Clin Rheumatol       Date:  2019-04-10       Impact factor: 2.980

Review 4.  JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.

Authors:  Daniella M Schwartz; Yuka Kanno; Alejandro Villarino; Michael Ward; Massimo Gadina; John J O'Shea
Journal:  Nat Rev Drug Discov       Date:  2017-11-06       Impact factor: 84.694

5.  JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.

Authors:  Daniella M Schwartz; Yuka Kanno; Alejandro Villarino; Michael Ward; Massimo Gadina; John J O'Shea
Journal:  Nat Rev Drug Discov       Date:  2017-12-28       Impact factor: 84.694

Review 6.  JAK inhibitors in dermatology: The promise of a new drug class.

Authors:  William Damsky; Brett A King
Journal:  J Am Acad Dermatol       Date:  2017-01-28       Impact factor: 11.527

Review 7.  Pathogenesis and Treatment of T-Large Granular Lymphocytic Leukemia (T-LGLL) in the Setting of Rheumatic Disease.

Authors:  Nina Couette; Wael Jarjour; Jonathan E Brammer; Alexa Simon Meara
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

Review 8.  JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis.

Authors:  George E Fragoulis; Iain B McInnes; Stefan Siebert
Journal:  Rheumatology (Oxford)       Date:  2019-02-01       Impact factor: 7.580

Review 9.  Human hepatitis viruses-associated cutaneous and systemic vasculitis.

Authors:  Chrong-Reen Wang; Hung-Wen Tsai
Journal:  World J Gastroenterol       Date:  2021-01-07       Impact factor: 5.742

10.  Coexistence of Polyarteritis Nodosa of the Vulva and Retina in a Behçet's Disease Patient: A Case Report.

Authors:  Amal O Al-Balbeesi; Rama A Alhallaf; Najlaa A Alsubeeh; Amany A Fathaddin; Asma A Bedaiwi; Mohammed A Omair
Journal:  Cureus       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.